April 30, 2012
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
I. Renewal update: We have almost all of the programs under final review, and the core facilities are close behind. We anticipate a hard month of effort and submission in 24 days, but who is counting?
II. Site Visit date announced: The site visit will be October 23, 2012. More information will follow regarding individual member involvement in the preparation and actual site visit.
III. External Advisory Board: The EAB meets September 7, 2012 in preparation of the site visit.
IV. Update on NCI plans for Cooperative Groups: While there have been many meetings, discussions and efforts to anticipate the formal announcement, NCI is now cautiously planning a program announcement about the re-competition for the cooperative groups.
Based on my meeting with Harold Varmus on April 18, 2012, three phases are anticipated:
Mitch Machtay leads the Case CCC Cooperative Group Committee and reports to the Executive Committee of the Cancer Center. We have had discussions about beginning the process now to assemble a Cancer Center coordinated response to the U10 RFA when it is released. If you have interest in participating please contact Mitch at Mitchell.Machtay@UHhospitals.org. We do not anticipate the need to curtail any involvement investigators have with any cooperative group, and we feel that the institution is well situated to be very responsive to this transition.
I would note that as a cancer center, we are the only center with four representatives on the NCI disease steering committees that oversee setting of priorities for approved clinical trials within the groups. Members considering a large phase 3 clinical trial should review the protocol with either:
The executive summary for the cancer genomics initiative will be posted next week for comments.
CASE CCC IN THE NEWS
Cleveland Clinic Follows University Hospitals in Offering Low-cost, Low-dose CT Scan for Lung-cancer Screening
Study Finds Mammography Beneficial for Younger Women
Texture of Surroundings Influences Human Embryonic Stem Cell Behavior
MARK YOUR CALENDARS
Cancer Center Seminar Series: Ontogeny of Erythropoiesis: Surprises from the Mammalian Embryo
Friday, May 4
Please join us May 4 for the next Cancer Center Seminar Series where Dr. James Palis will present Ontogeny of Erythropoiesis: Surprises from the Mammalian Embryo.
Dr. Palis is Professor of Pediatrics, Hematology and Oncology (SMD) at the University of Rochester. His laboratory has a particular interest and expertise in the embryonic development of the hematopoietic system using the mouse as a model system. In the adult, all blood cells are derived from hematopoietic stem cells. However, studies in the mouse embryo indicate that primitive and definitive erythroid potential emerge before the appearance of blood stem cells and constitute part of a transient hematopoietic system that arises in the yolk sac and seeds the early fetal liver. Analysis of these erythroid cells reveals several "surprises", including the ability of embryonic erythroblasts to extensively self-renew ex vivo.
Sequence-Palooza: What Can Next Gen Sequencing Do For You?
The CWRU Genome and Transcriptome Sequencing Core (GTSC) is pleased to announce an event, Sequence-Palooza: What Can Next Gen Sequencing Do For You?, devoted to next-gen sequencing. On May 10 from 11-3 pm, experts from the GTSC will be on hand in BRB 105 and the atrium to provide guidance on incorporating this technology into your research program. Learn about ways for identifying genetic or epigenetic markers for disease states, expression profiling in healthy versus diseased individuals, retrospective analyses of tissue samples and many more.
Comparative Effectiveness Research: From All Angles
Register today for Comparative Effectiveness Research: From All Angles. Co-Sponsored by the Clinical and Translational Science Collaborative, this second annual two-day conference will be held May 21-22 in SOM E401. Many expert speakers will be covering a variety of topics including: methods, policy, physician practice, public acceptance, economics of payment, health care organizations, and ethical/legal/social issues. Discounted registration available for interns, residents, fellows, full-time students and employees of public health departments. (CME application pending; also for course credit EPBI 467).
Biennial Science of Global Prostate Cancer Disparities conference
The Technical Planning Committee Chairs and Co-Chairs for the "Biennial Science of Global Prostate Cancer Disparities conference" are pleased to announce that the opening plenary session keynote address to kick off the conference will be presented by Dr. Edward Trimble, Director of the NCI Center for Global Health. The NCI-supported Biennial Conference is scheduled for November 1-4 in Nassau, The Bahamas. With delegates from North America, South America, Europe, Africa and the Caribbean, this conference is a landmark effort to continue to address the global burden of prostate cancer in Black men. The conference will attract national and international scientists, clinicians, community leaders, prostate cancer survivors, prostate cancer advocates and other urological professionals.
Conference registration and late-breaking abstract submission begins on May 1. The conference will start with International Educational Workshops on November 1. Professor Isaac Adewole, the President of the African Organisation for Research and Training in Cancer (AORTIC), will give the International Keynote address. In addition to the scientific plenary sessions, and the special symposia for providers, patients, and advocates, ancillary meetings will be held by the Prostate Cancer Transatlantic Consortium (CaPTC), the African-Caribbean Cancer Consortium (AC3), Men of African Descent and Prostate Cancer (MADCaP), and AORTIC.
Society of Surgical Oncology Clinical Investigator Award in Breast Cancer Research
The Society of Surgical Oncology is accepting applications for the Clinical Investigator Award in Breast Cancer Research. The purpose of this award is to promote patient-oriented breast cancer research conducted by mid-level surgical oncologists in clinical and translational science. Applicants must be surgical oncologists within ten years of completion of training and be full SSO members.
Deadline: July 9
Race for the Place- Join Our Team!
The Race for the Place, an event that benefits the Gathering Place, will be held Sunday, June 3 at Beachwood Place Mall. The Case CCC has created a CaseCCC Trainees team. Click here to join the team or to show your support by making a donation. Contact Lyn Haselton, Case CCC Training Program Manager, at 216.844.5375 or email@example.com for more information.
**All events are open to anyone interested in attending
Pathology Research Seminar Series
Chair of Cancer Biology Candidate Seminar
Molecular Biology and Microbiology Thesis Defense
Hematology and Oncology Division Research Conference
Immunology Students/Fellows Research in Progress Series
Molecular Genetics Seminar
Department of Biomedical Engineering Special Seminar
Molecular Biology and Microbiology Seminar
Taussig Cancer Institute Grand Rounds
Case GI Cancers SPORE Retreat
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Case CCC Scientific Series: Imaging Research
Ca-PRI Annual Meeting: Learning from Our Differences
ADDITIONAL UPCOMING SEMINARS & EVENTS
Cleveland Clinic 2012 Personalized Healthcare Summit
Ninth International Conference of the Society for Integrative Oncology
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
American Nurses Foundation Nursing Research Grants
Doctors Cancer Foundation, Inc.
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.